“Intuitive Surgical (ISRG) has been reiterated by TheStreet Ratings as a buy with a ratings score of A- . The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.”
,” TheStreet’s analyst commented.
Other equities research analysts have also recently issued reports about the stock. Analysts at Northland Securities initiated coverage on shares of Intuitive Surgical in a research note to investors on Monday. They set an underperform rating and a $400.00 price target on the stock. Separately, analysts at Northland Capital initiated coverage on shares of Intuitive Surgical in a research note to investors on Monday. They set an under perform rating and a $400.00 price target on the stock. Finally, analysts at SunTrust reiterated a buy rating on shares of Intuitive Surgical in a research note to investors on Friday, March 1st. They now have a $649.00 price target on the stock.
Shares of Intuitive Surgical traded down 1.59% during mid-day trading on Tuesday, hitting $511.54. Intuitive Surgical has a one year low of $467.26 and a one year high of $594.89. The stock’s 50-day moving average is currently $559.0. The company has a market cap of $20.527 billion and a P/E ratio of 32.53.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.